Validation of new dynamic prognostic index for lymphoma in Thai patients: International metabolic prognostic index

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240611002

Enrollment

188

Registered

2024-06-11

Start date

2023-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed adult patients aged greater 18 years with histologically proven lymphoma (DLBCL, FL, HL, PTCL, or NK/T cell lymphoma) New dynamic prognostic index, International metabolic prognostic index, Lymphoma

Interventions

1.Newly diagnosed adult patients aged greater 18 years with histologically proven lymphoma 2.Patients underwent PET/CT scans (before chemotherapy) at Siriraj hospital 3.A minimum of 1 year of foll

Diagnostic

Newly diagnosed adult patients aged greater 18 years with histologically proven lymphoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed adult patients aged greater 18 years with histologically proven lymphoma 2.Patients underwent PET/CT scans (before chemotherapy) at Siriraj hospital 3.A minimum of 1 year of follow-up for surviving patients

Exclusion criteria

Exclusion criteria: 1.Other malignancy or active sarcoidosis or active granulomatous infection 2.No assessable disease on baseline PET/CT

Design outcomes

Primary

Measure	Time frame
Progression free survival 3 years Progression free survival of lymphoma using MTV as prognostic index at diagnosis	—

Secondary

Measure	Time frame
Overall survival 3 years Overall survival of lymphoma using MTV as prognostic index at diagnosis	—

Countries

Thailand

Contacts

Public ContactWeerapat Owattanapanich

Faculty of Medicine Siriraj Hospital, Mahidol University.

weerapato36733@gmail.com0891081983

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026